8-K: Integrated Wellness Acquisition Corp Faces Delisting from NYSE, Extends Business Combination Deadline

Integrated Wellness Acquisition Corp received a delisting notice from the NYSE due to failure to complete a business combination within the required timeframe, while also extending its deadline to December 15, 2025.

Summary

• Integrated Wellness Acquisition Corp received a delisting notice from the New York Stock Exchange (NYSE) because it did not complete a business combination within the required timeframe.
• Trading of the company's securities on the NYSE was suspended on December 13, 2024, and they will now trade on the OTC Markets under the symbols WELUF, WELNF, and WELWF.
• The company has the right to appeal the delisting decision.
• The company's shareholders approved an extension to the deadline for completing a business combination to December 15, 2025.
• Shareholders also approved a measure allowing the board to wind up operations earlier than December 15, 2025.
• Approximately $36.7 million, or $11.96 per share, was removed from the trust account to pay shareholders who exercised their redemption rights.
• Following redemptions, 1,185,481 Class A ordinary shares remain outstanding.
• Suren Ajjarapu resigned as CEO, and Matthew Malriat, the current CFO, was appointed as the new CEO.
• The company intends to apply to list on the Nasdaq Stock Market in connection with the closing of its initial business combination.

Sentiment

Score: 3

Explanation: The document contains significant negative news, including delisting from the NYSE, CEO resignation, and substantial shareholder redemptions. While the extension of the deadline provides some hope, the overall sentiment is negative.

Positives

• The company has extended the deadline to complete a business combination to December 15, 2025, providing more time to find a suitable target.
• The company intends to apply to list on the Nasdaq Stock Market, which could provide better visibility and access to capital.
• The company remains a reporting entity under the Securities Exchange Act of 1934, ensuring continued disclosure of financial and operational information.

Negatives

• The company received a delisting notice from the NYSE due to failure to complete a business combination within the required timeframe.
• Trading of the company's securities on the NYSE was suspended.
• A significant amount of funds, approximately $36.7 million, was removed from the trust account due to shareholder redemptions.
• The company's CEO, Suren Ajjarapu, resigned.

Risks

• The company faces the risk of not completing a business combination by the extended deadline of December 15, 2025, which could lead to liquidation.
• The delisting from the NYSE could negatively impact investor confidence and the company's ability to raise capital.
• The company's transition to the OTC Markets may result in lower trading volume and liquidity.
• The change in CEO could create uncertainty and disruption within the company.

Future Outlook

The company intends to apply to list on the Nasdaq Stock Market in connection with the closing of its initial business combination. The company has until December 15, 2025, to complete a business combination or face liquidation.

Management Comments

• The delisting process does not affect the Company's business operations.
• The Company will remain a reporting entity under the Securities Exchange Act of 1934, as amended (the Exchange Act), ensuring continued disclosure of financial and operational information.

Industry Context

The delisting of Integrated Wellness Acquisition Corp highlights the challenges faced by SPACs in completing business combinations within the specified timeframes. The company's move to the OTC Markets is a common outcome for SPACs that fail to meet listing requirements. The extension of the deadline to December 15, 2025, is a common strategy to provide more time to find a suitable target.

Comparison to Industry Standards

• The delisting from the NYSE is a negative outcome, as most SPACs aim to maintain their listing on major exchanges like the NYSE or Nasdaq.
• The redemption rate of 3,069,636 shares is significant and indicates a lack of shareholder confidence in the company's ability to complete a business combination.
• The extension of the deadline to December 15, 2025, is a common practice among SPACs facing difficulties in finding a target, but it also increases the risk of liquidation if a deal is not completed.
• The move to the OTC Markets is a common step for companies that have been delisted from major exchanges, but it typically results in lower trading volume and liquidity.

Management Changes

Stakeholder Impact

• Shareholders have experienced a loss of value due to the delisting and redemptions.
• Employees may face uncertainty due to the company's challenges.
• The company's ability to attract a suitable business combination target may be affected.

Next Steps

• The company will apply to list on the Nasdaq Stock Market.
• The company will continue to seek a business combination target.
• The company may appeal the NYSE delisting decision.

Key Dates

Keywords

delisting, business combination, NYSE, OTC Markets, redemption, CEO resignation, Nasdaq, SPAC, extension, liquidation